Compounds and methods for inhibiting selectin-mediated function
    1.
    发明申请
    Compounds and methods for inhibiting selectin-mediated function 有权
    抑制选择蛋白介导功能的化合物和方法

    公开(公告)号:US20060194745A1

    公开(公告)日:2006-08-31

    申请号:US11411266

    申请日:2006-04-26

    IPC分类号: A61K31/7034

    CPC分类号: C07H15/252

    摘要: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids, which include a portion or analogue thereof linked to a carbohydrate or glycomimetic.

    摘要翻译: 提供化合物和方法用于调节由选择素结合介导的体外和体内过程。 更具体地,描述了选择素调节剂及其用途,其中调节(例如,抑制或增强)选择素介导的功能的选择素调节剂包含称为BASAs的一类化合物(苄基氨基磺酸,其包括其部分或类似物连接 到糖或糖模拟物。

    Specific antagonist for both E- and P-selectins
    2.
    发明申请
    Specific antagonist for both E- and P-selectins 有权
    E-和P-选择素的特异性拮抗剂

    公开(公告)号:US20050164982A1

    公开(公告)日:2005-07-28

    申请号:US10992480

    申请日:2004-11-18

    CPC分类号: C07H15/18

    摘要: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise a particular glycomimetic linked to a particular BASA (Benzyl Amino Sulfonic Acid).

    摘要翻译: 提供化合物和方法用于调节由选择素结合介导的体外和体内过程。 更具体地,描述了选择素调节剂及其用途,其中调节(例如,抑制或增强)选择素介导的功能的选择素调节剂包含与特定BASA(苄基氨基磺酸)连接的特定的糖模拟物。

    Heterobifunctional pan-selectin inhibitors
    3.
    发明申请
    Heterobifunctional pan-selectin inhibitors 有权
    异双功能泛选择素抑制剂

    公开(公告)号:US20070054870A1

    公开(公告)日:2007-03-08

    申请号:US11515343

    申请日:2006-09-01

    摘要: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics alone or linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).

    摘要翻译: 提供化合物和方法用于调节由选择素结合介导的体外和体内过程。 更具体地,描述了选择素调节剂及其用途,其中调节(例如,抑制或增强)选择素介导的功能的选择素调节剂单独包含特定的糖模拟物或连接到称为BASAs的化合物类别(苄基氨基磺酸 )或称为BACAs(苄基氨基羧酸)的一类化合物的成员。

    Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas
    4.
    发明申请
    Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from pseudomonas 有权
    来自假单胞菌的PA-IL凝集素,PA-IIL凝集素或两者的凝集素的模拟抑制剂

    公开(公告)号:US20070037775A1

    公开(公告)日:2007-02-15

    申请号:US11501464

    申请日:2006-08-08

    IPC分类号: A61K31/739 C12Q1/04 C08B37/00

    摘要: Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with Pseudomonas bacteria. Such infections include Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. A compound useful in the present methods may be used in combination with a therapeutic agent or may be linked to a therapeutic agent. Pseudomonas bacteria may be inhibited by blocking colonization, inhibiting virulence factors, arresting growth or killing the bacteria.

    摘要翻译: 提供了与假单胞菌属相关的组合物和方法。 组合物和方法可用于诊断和治疗涉及感染假单胞菌的医学病症。 这种感染包括铜绿假单胞菌在囊性纤维化患者的肺部。 可用于本发明方法的化合物可与治疗剂组合使用或可与治疗剂连接。 通过阻断定植,抑制毒力因子,阻止生长或杀死细菌,可以抑制假单胞菌。

    Glycomimetic antagonists for both E-and P-selectins
    5.
    发明申请
    Glycomimetic antagonists for both E-and P-selectins 审中-公开
    用于E-选择素和P-选择蛋白的糖模拟拮抗剂

    公开(公告)号:US20050187171A1

    公开(公告)日:2005-08-25

    申请号:US10992238

    申请日:2004-11-18

    摘要: Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids).

    摘要翻译: 提供化合物和方法用于调节由选择素结合介导的体外和体内过程。 更具体地,描述了选择素调节剂及其用途,其中调节(例如,抑制或增强)选择素介导的功能的选择素调节剂包含与称为BASAs(苄基氨基磺酸)的一类化合物的成员连接的特定糖模拟物。

    Detection and treatment of prostate cancer
    6.
    发明申请
    Detection and treatment of prostate cancer 有权
    前列腺癌的检测与治疗

    公开(公告)号:US20070048809A1

    公开(公告)日:2007-03-01

    申请号:US11541830

    申请日:2006-10-02

    申请人: John Magnani

    发明人: John Magnani

    IPC分类号: G01N33/574

    摘要: An antigen is shown to be associated with prostate cancer, and is useful for new methods and compositions for diagnosing or treating prostate cancer. This is particularly useful for individuals with prostate cancer who test negative for Prostate Specific Antigen. Additionally, this is useful for distinguishing between benign prostate disease and prostate cancer in a patient diagnosed or presenting with prostate dysfunction.

    摘要翻译: 抗原显示与前列腺癌相关,并且可用于诊断或治疗前列腺癌的新方法和组合物。 这对于前列腺特异性抗原阴性的前列腺癌患者特别有用。 另外,这对于在诊断或呈现前列腺功能障碍的患者中区分良性前列腺疾病和前列腺癌是有用的。